Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the only touchscreen insulin pumps available in the United St ...

Tandem to offer any t:slim X2 Insulin Pump features approved in 2018 to users at no cost via remote software updates.

More than 200 people with diabetes have been injured when their insulin pumps shut down unexpectedly due to a problem with a connected mobile app, the US Food and Drug Administration said Wednesday.

Tandem found that a bug in the app’s software is causing the app to repeatedly crash and relaunch, draining the insulin pump’s battery through unnecessary Bluetooth communication.

Tandem Diabetes Care, the maker of the t:slim insulin pump, has partnered with open-source software provider Tidepool. The deal is expected to better enable diabetes patients using the pump to ...

Tandem Diabetes Care has announced that its t:slim X2 insulin pump, featuring Control-IQ automated insulin delivery technology, received approval for use with the ultra-rapid-acting insulin ...

Tandem Diabetes Care emailed notices to users of version 2.7.1 of the Apple iOS t:connect mobile app warning of possible rapid battery depletion of their insulin pump, according to an FDA press ...

Tandem Diabetes Care enrolled the first patients in a pivotal trial of a system, based on its touchscreen insulin pump, that automatically stops insulin delivery when a patient’s blood glucose ...

Tandem Diabetes (TNDM -0.15%) today announced the commercial launch of the newest version of its flagship insulin pump in the U.S. market. The company's signature t:slim X2 insulin pump will also ...

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company today announced the Tandem t: slim X2™ insulin pump with Control-IQ+ automated insulin delivery technology ...